The risk of developing Alzheimer’s disease in people with DS (AD-DS) is greatly elevated due to the gene overexpression produced by the chromosome 21 trisomy, in which amyloid precursor protein and other gene modulations involve an accumulation of extracellular amyloid beta and neurofibrillary tangles [3,4]. This evidence concerns the gene APP and Alzheimer disease.